Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000227522

Medchemexpress LLC Vipivotide tetraxetan | 1702967-37-0 | MFCD31715458 | 99.5% | 1042.14 | C49H71N9O16 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY11741050MG

Encompass_Preferred

Vipivotide tetraxetan is a DOTA-conjugated small-molecule ligand that selectively binds prostate-specific membrane antigen (PSMA) and is supplied as a research precursor for radiolabeling with diagnostic and therapeutic radionuclides. It is used in preclinical and clinical research for PSMA-targeted imaging and radioligand therapy.

  • DOTA-conjugated PSMA-targeting ligand suitable for radiolabeling with lutetium-177 or gallium-68.
  • High binding affinity for PSMA enabling targeted imaging and therapy applications.
  • Supplied with high purity (≈99.5%), appropriate for research use.
  • Available in multiple pack sizes, including 50 mg for synthesis and labeling workflows.
  • Useful as a precursor for developing PSMA-targeted radiopharmaceuticals.

Catalog No. 50-002-27522


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.